Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT06065202
Other study ID # Pro00112343
Secondary ID
Status Recruiting
Phase Phase 2
First received
Last updated
Start date April 12, 2024
Est. completion date December 30, 2024

Study information

Verified date May 2024
Source Duke University
Contact Krista Haines, MD
Phone 919-681-3784
Email krista.haines@duke.edu
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The purpose of this study is to determine if a particular method of providing nutrition improves the outcomes of patients in the intensive care unit (ICU) who have undergone abdominal surgery following trauma and would require nutrition delivered via the bloodstream (called total parenteral nutrition or TPN). The nutrition method being tested is a structured nutrition delivery plan, called the SeND Home pathway, that involves TPN, oral nutrition supplements, and the use of a device (called an indirect calorimeter or IC) to measure calorie needs. Participants will be randomly assigned (like the flip of a coin) to the SeND Home program or standard of care nutrition. In the SeND Home program, participants will receive TPN, followed by oral nutrition supplements (shakes) for 4 weeks after discharge. The control group will follow standard of care nutrition delivery that begins during ICU stay and concludes at hospital discharge. Participants in both groups will undergo non-invasive tests that measure how much energy (calories) they are using, body composition, and muscle mass and complete walking and strength tests, and surveys about quality of life.


Description:

Severe abdominal trauma can impact patients in a variety of ways. Current data shows that trauma patients can experience problems with physical function, muscle weakness, and poor quality of life after they are released from the hospital. There is a critical need to improve nutrition in trauma patients with severe abdominal injuries to optimize the recovery process. The purpose of this study is to evaluate if the use of a planned nutrition delivery plan with early intravenous (IV) nutrition will improve outcomes. Participants will be randomly assigned 1:1, like flipping a coin, to the SeND Home program or routine care. Participants in the standard of care program will receive standard nutrition delivery as determined by clinical care providers. This may include TPN. Participants in the SeND Home program will receive TPN within 72 hours of abdominal surgery. Indirect calorimetry will be used to determine nutrition needs.Once participants are able to have a liquid diet they will receive nutrition shakes up to 3 times a day while in the hospital and for 4 weeks after discharge. Participants will undergo tests to measure muscle mass, have blood draws, complete walking and strength tests, and surveys about quality of life. These tests will be done at several times throughout hospitalization and participants will be asked to return for a 3 month follow-up visit.


Recruitment information / eligibility

Status Recruiting
Enrollment 150
Est. completion date December 30, 2024
Est. primary completion date September 30, 2024
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: - 18+ years old - Penetrating abdominal trauma requiring emergent major abdominal surgery - Admitted to the surgical ICU - Not expected to receive oral nutrition for 72 hours or more Exclusion Criteria: - Patients who are unable to ambulate at baseline - Expected withdrawal of life-sustaining treatment within 48 hours - Prisoners - Positive pregnancy test for women of child bearing potential.

Study Design


Related Conditions & MeSH terms


Intervention

Dietary Supplement:
Nutrition Supplement
Total parenteral nutrition (TPN) will be administered within 72 hours of abdominal surgery. Nutritional shakes will be started with a liquid diet and given 3 times a day. This will continue for 4 weeks after discharge.

Locations

Country Name City State
United States Duke University Hospital Durham North Carolina

Sponsors (3)

Lead Sponsor Collaborator
Duke University Baxter Healthcare Corporation, United States Department of Defense

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Change in six-minute walk distance (6 MWD) Change in 6MWD from baseline to day 14 or hospital discharge will be compared between the two study arms 3 months
Secondary Change in physical function This will be measured by comparing the changes in physical function tests (4 meter walk, sit-to-stand) between the two study arms. baseline, day 14 or hospital discharge, 3 and 6 months post-hospital discharge
Secondary Change in muscle strength This will be measured by comparing the changes in grip and quad strength tests between the two study arms. baseline, hospital discharge, 3 and 6 months post-hospital discharge
Secondary Change in muscle mass This will be measured by comparing changes in bioelectrical impedance analysis (BIA) between the two study arms. baseline, hospital discharge, 3 and 6 months post-hospital discharge
Secondary Change in Quality of Life (QoL) This will be measured by comparing changes in the EuroQoL-5 Dimension and 43-item Trauma Specific Quality of Life measurement between the two study arms. baseline, 3 and 6 months post-hospital discharge
Secondary Change in cognition This will be measured by looking at changes in mental health and cognition via questionnaires. baseline, 3 and 6 months post-hospital discharge
Secondary Infection This will be measured by looking at the number of infections reported. hospital discharge, 3 and 6 months post-hospital discharge
Secondary Length of Hospital/ICU stay This will be measured by recording the length of hospital stay noted in the medical record. hospital discharge
Secondary Mortality rate This will be measured by survival after 6 months. 6 months post-hospital discharge
Secondary Change in muscle mitochondrial metabolism This will be measured by doing urine and blood tests. admission, day 14, and hospital discharge
Secondary Change in key resilience and inflammation biomarkers This will be measured utilizing the Duke Pepper Panel which serves as a comprehensive set of biological indicators typically incorporating: hormones, inflammatory markers and genomic factors. admission, day 14, and hospital discharge
See also
  Status Clinical Trial Phase
Completed NCT05025449 - BEFAST (Bubble-Enhanced FAST) for the Evaluation of Solid Organ Injury Phase 4
Completed NCT05538390 - Assessment of Pattern of Abdominal Injury
Completed NCT01938885 - Hepatic Pseudoaneurysms After Trauma N/A
Recruiting NCT05627908 - The PseAn Study - Study Protocol
Recruiting NCT06182488 - Enhanced Recovery After Surgery (ERAS) in Patients Undergoing Emergency Laparotomy N/A
Completed NCT02728609 - An Analysis of Cytokine Concentration in Open Abdominal Closure of Trauma Patients N/A
Enrolling by invitation NCT05805852 - Challenges in Management of Abdominal Trauma in Sohag University Hospital A Prospective Study
Not yet recruiting NCT02952976 - Study of Primary Fascial Closure Rate in Patients With Open Abdomen Treated With Abthera Versus Barker Technique Phase 3
Completed NCT03952026 - Impact of Associated Abdominal Injuries on Clinical and Operative Outcome in Pelvic Injuries
Recruiting NCT05127109 - The PASTDUe Nutrition Ecosystem Project (PASTDUe) Phase 4
Not yet recruiting NCT06180668 - Global Outcomes After Laparotomy for Trauma
Completed NCT01763840 - Contrast Enhanced Ultrasound for Evaluation of Pediatric Abdominal Trauma Phase 1
Recruiting NCT03815370 - A Non-Traumatic Binder for Temporary Abdominal Wall Closure N/A